[go: up one dir, main page]

WO2008001311A3 - Composition pharmaceutique associant une dose fixe d'aténolol et une dose fixe de mononitrate d'isosorbide - Google Patents

Composition pharmaceutique associant une dose fixe d'aténolol et une dose fixe de mononitrate d'isosorbide Download PDF

Info

Publication number
WO2008001311A3
WO2008001311A3 PCT/IB2007/052479 IB2007052479W WO2008001311A3 WO 2008001311 A3 WO2008001311 A3 WO 2008001311A3 IB 2007052479 W IB2007052479 W IB 2007052479W WO 2008001311 A3 WO2008001311 A3 WO 2008001311A3
Authority
WO
WIPO (PCT)
Prior art keywords
atenolol
pharmaceutical composition
isosorbide mononitrate
composition containing
fixed dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/052479
Other languages
English (en)
Other versions
WO2008001311A2 (fr
Inventor
Rajan K Verma
Narayanan Badri Viswanathan
Ashok Rampal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2008001311A2 publication Critical patent/WO2008001311A2/fr
Publication of WO2008001311A3 publication Critical patent/WO2008001311A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne une composition pharmaceutique associant une dose fixe d'aténolol et une dose fixe de mononitrate d'isosorbide, ainsi que le procédé de préparation de celle-ci. La composition assure une libération prolongée du mononitrate d'isosorbide et une libération immédiate de l'aténolol.
PCT/IB2007/052479 2006-06-26 2007-06-26 Composition pharmaceutique associant une dose fixe d'aténolol et une dose fixe de mononitrate d'isosorbide Ceased WO2008001311A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1491DE2006 2006-06-26
IN1491/DEL/2006 2006-06-26

Publications (2)

Publication Number Publication Date
WO2008001311A2 WO2008001311A2 (fr) 2008-01-03
WO2008001311A3 true WO2008001311A3 (fr) 2008-05-15

Family

ID=38606877

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/052479 Ceased WO2008001311A2 (fr) 2006-06-26 2007-06-26 Composition pharmaceutique associant une dose fixe d'aténolol et une dose fixe de mononitrate d'isosorbide

Country Status (1)

Country Link
WO (1) WO2008001311A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058592B (zh) * 2010-12-27 2012-10-10 青岛黄海制药有限责任公司 一种阿折地平硝酸异山梨酯复方组合物
CN116139091A (zh) * 2023-03-29 2023-05-23 山东诚创蓝海医药科技有限公司 一种单硝酸异山梨酯片及其制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
WO1998053802A1 (fr) * 1997-05-30 1998-12-03 Laboratorios Phoenix U.S.A., Inc. Dispositif a osmose multicouches
WO2000057883A1 (fr) * 1999-03-29 2000-10-05 Bristol-Myers Squibb Company Utilisation d'inhibiteurs de la vasopeptidase pour traiter l'angine de poitrine
EP1260216A1 (fr) * 2001-05-15 2002-11-27 Peirce Management, LLC Composition pharmaceutique multicouche destinee a une administration a la fois orale et intraorale
US20030216384A1 (en) * 2002-05-16 2003-11-20 Northern Sydney Area Health Service Composition and method for treating hypertension
WO2004087175A1 (fr) * 2003-04-04 2004-10-14 Pharmacia Corporation Tablettes comprimees orales de formulations multiparticulaires a liberation prolongee
WO2005009412A1 (fr) * 2003-07-24 2005-02-03 Wockhardt Limited Compositions orales pour le traitement de maladies
US20060018934A1 (en) * 2002-08-05 2006-01-26 Navin Vaya Novel drug delivery system

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
WO1998053802A1 (fr) * 1997-05-30 1998-12-03 Laboratorios Phoenix U.S.A., Inc. Dispositif a osmose multicouches
WO2000057883A1 (fr) * 1999-03-29 2000-10-05 Bristol-Myers Squibb Company Utilisation d'inhibiteurs de la vasopeptidase pour traiter l'angine de poitrine
EP1260216A1 (fr) * 2001-05-15 2002-11-27 Peirce Management, LLC Composition pharmaceutique multicouche destinee a une administration a la fois orale et intraorale
US20030216384A1 (en) * 2002-05-16 2003-11-20 Northern Sydney Area Health Service Composition and method for treating hypertension
US20060018934A1 (en) * 2002-08-05 2006-01-26 Navin Vaya Novel drug delivery system
WO2004087175A1 (fr) * 2003-04-04 2004-10-14 Pharmacia Corporation Tablettes comprimees orales de formulations multiparticulaires a liberation prolongee
WO2005009412A1 (fr) * 2003-07-24 2005-02-03 Wockhardt Limited Compositions orales pour le traitement de maladies

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AKHRAS, F. ET AL: "Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.", LANCET, vol. 338, 26 October 1991 (1991-10-26), XP002457110 *

Also Published As

Publication number Publication date
WO2008001311A2 (fr) 2008-01-03

Similar Documents

Publication Publication Date Title
HUS2400009I1 (hu) Glükopiranozil-helyettesített benzonitril-származékok, ilyen vegyületeket tartalmazó gyógyászati készítmények, alkalmazásuk és elõállításukra alkalmas eljárás
IL225198A (en) Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
WO2011077043A3 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
IL193385A0 (en) Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
IL233677A (en) Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition
ZA200900347B (en) Preparation of pharmaceutical compositions
ZA201007170B (en) Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
IL210549A (en) Pipedrine - Quinocosalin-Mediated Conjugated Drugs
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
WO2010055082A3 (fr) Nouvelle forme cristalline de malate de sunitinib
IL206562A0 (en) Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
WO2007130822A3 (fr) Modulateurs des récepteurs mglur5 iii
IL195039A0 (en) Pharmaceutical compositions containing oridonin
ZA201003794B (en) Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
WO2008154234A3 (fr) Formulation à libération prolongée de névirapine
ZA201009072B (en) Pharmaceutical composition for the treatment of premature ejaculation
PL2231598T3 (pl) Nowe pochodne diazeniodiolanów, sposób ich wytwarzania i kompozycje farmaceutyczne je zawierające
ZA201102652B (en) Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormane (gnrh) as immunogen
WO2009069151A3 (fr) Composition à libération contrôlée
ZA200804802B (en) Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
ZA200806399B (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
WO2008001311A3 (fr) Composition pharmaceutique associant une dose fixe d'aténolol et une dose fixe de mononitrate d'isosorbide
IL198634A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
IL200951A0 (en) Aryl-sulphonamid compounds, compositions comprising the same, processes for the preparation of the same and uses thereof
WO2008064829A3 (fr) Nouveaux dérivés d'aminothiénopyridinone, procédés de préparation de ces dérivés et compositions pharmaceutiques à base de ceux-ci

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07789809

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU